live attenuated influenza virus vaccine (flumist) Report issue

Active Ingredient History

NOW
  • Now
Live attenuated influenza vaccine (LAIV) is a type of influenza vaccine in the form of a nasal spray that is recommended for the prevention of influenza. In June 2016, the Centers for Disease Control and Prevention (CDC) stopped recommending the use of LAIV as its effectiveness had appeared to have decreased between 2013 and 2016, but this recommendation was reversed in February 2018, for the 2018-2019 influenza season.   Wikipedia

More Chemistry
a/california/07/09 live monovalent h1n1 vaccine | caivt | caiv-t | cold-adapted influenza vaccine trivalent | flumist | flumist/b/victoria | flumist/b/yamagata | flumist quadrivalent | influenza vaccine live, intranasal | live attenuated h1n1 influenza vaccine | live attenuated h2n3 influenza virus vaccine | live attenuated h7n9 anhui 2013/aa ca | live attenuated influenza vaccine | live, attenuated influenza vaccine | live attenuated influenza virus | live attenuated monovalent a/17/mallard/netherlands/00/95(h7n3) influenza vaccine | live, trivalent influenza vaccine | quadrivalent live attenuated influenza vaccine | quadrivalent live attenuated influenza vaccine, q/laiv | trivalent flumist

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue